Also trades as: BSLN.SW (SIX) · $vol 3M · 0QNA.L (LSE) · $vol 1M

$76.25

-1.15 (-1.49%)

Weekly Expected Move ±0.7%

$75 $76 $76 $77 $77

OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 66 · $943.7M mcap · 11M float · 0.0003% daily turnover · Short 100% of daily vol

Revenue

$233M +11.5% ▲

5Y CAGR: +12.7%

Gross Profit

$193M +13.7% ▲

5Y CAGR: +13.3%

Operating Income

$52M -15.6% ▼

Net Income

$40M -48.2% ▼

EPS (Diluted)

$3.14 -46.1% ▼

EBITDA

$52M -22.2% ▼

View Full Income Statement

Line Item	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	$148M	$148M	$158M	$209M	$233M
YoY Growth	+16.1%	-0.2%	+6.7%	+32.3%	+11.5%
Cost of Revenue	$24M	$25M	$27M	$39M	$39M
Gross Profit	$124M	$123M	$131M	$170M	$193M
Gross Margin	83.7%	83.3%	83.0%	81.5%	83.1%
R&D Expenses	$93M	$74M	$78M	$77M	$106M
SG&A Expenses	$30M	$31M	$34M	$32M	$36M
Operating Expenses	$30M	$31M	$112M	$109M	$142M
Operating Income	$1M	$19M	$19M	$61M	$52M
Operating Margin	0.8%	12.5%	12.2%	29.3%	22.2%
Interest Expense	$8M	$10M	$11M	$4M	$0
Income Before Tax	-$7M	$12M	$10M	$60M	$46M
Tax Expense	$37K	-$45K	$10K	-$17M	$6M
Net Income	-$7M	$12M	$10M	$78M	$40M
Net Margin	-4.6%	8.2%	6.6%	37.2%	17.3%
EPS (Diluted)	$-0.58	$1.02	$0.86	$5.83	$3.14
EBITDA	$4M	$22M	$23M	$66M	$52M
Shares Outstanding	12M	12M	12M	14M	13M

Line Item	FY2022 Q4	FY2023 Q2	FY2023 Q4	FY2024 Q2	FY2024 Q4	FY2025 Q2	FY2025 Q4	FY2026 Q2
Revenue	$89M	$85M	$73M	$76M	$132M	$104M	$129M	$118M
Cost of Revenue	$10M	$10M	$17M	$52M	-$13M	$63M	$15M	$15M
Gross Profit	$79M	$75M	$56M	$25M	$145M	$41M	$113M	$103M
Gross Margin	89.1%	88.2%	76.9%	32.2%	109.9%	39.9%	88.3%	87.0%
R&D Expenses	$37M	$21M	$56M	$34M	$44M	$38M	$68M	$54M
SG&A Expenses	$15M	$17M	$17M	$15M	$16M	$17M	$18M	$18M
Operating Expenses	$52M	$38M	$74M	$15M	$93M	$17M	$86M	$72M
Operating Income	$28M	$37M	-$18M	$9M	$52M	$24M	$28M	$31M
Operating Margin	31.0%	43.5%	-24.3%	12.1%	39.3%	23.1%	21.5%	26.5%
Interest Expense	$6M	$6M	$10M	$8M	-$3M	$1M	$1M	$1M
Income Before Tax	$24M	$32M	-$21M	$7M	$53M	$19M	$27M	$32M
Tax Expense	-$33K	$27K	-$17K	-$13M	-$4M	$4M	$2M	$4M
Net Income	$24M	$32M	-$21M	$21M	$57M	$16M	$24M	$28M
Net Margin	27.3%	37.5%	-29.4%	27.2%	43.0%	15.2%	19.0%	23.5%
EPS (Diluted)	$2.04	$2.31	$-1.78	$1.50	$4.20	$1.26	$2.00	$2.01
EBITDA	$16M	$21M	$3M	$10M	$56M	$25M	$29M	$34M
Shares Outstanding	12M	14M	12M	14M	14M	14M	12M	14M

BPMUF OTC